Aldeyra
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (35)
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
Started: 2/1/2026
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Started: 6/24/2024
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
Started: 1/26/2021
A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Started: 4/29/2024
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Started: 11/15/2019
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
Started: 4/9/2024
The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
Started: 8/28/2021
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Started: 3/30/2018
SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.
Started: 4/26/2017
The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Started: 4/16/2019
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.
Started: 12/5/2019
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
Started: 1/21/2022
RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
Started: 7/18/2018
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
Started: 11/4/2024
The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
Started: 11/21/2020
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis
Started: 5/7/2021
A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease
Started: 4/23/2019
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
Started: 4/7/2022
An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber
Started: 9/9/2021
A Clinical Trial to Assess Subjects With Dry Eye Disease.
Started: 6/15/2021
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.
Started: 3/31/2021
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)
Started: 1/9/2021
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
Started: 1/2/2018
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
Started: 5/15/2017
A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease
Started: 3/9/2022
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
Started: 2/15/2023
Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Started: 1/1/2023
A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis
Started: 8/1/2015
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
Started: 3/1/2015
A Study of ADX-102 in Subjects With Allergic Conjunctivitis
Started: 12/1/2016
A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Started: 3/1/2015
A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
Started: 9/8/2018
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels
Started: 11/15/2021
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
Started: 10/2/2018